Leaders, Visionaries, and Partners
We are …

Executive Team

Florencia Bollini

Founder CEO

Florencia Bollini

Founder CEO

Named "The Corporate Shaman" by Forbes Magazine, Flor has over a decade of experience as one of the pioneering practitioners of the plant medicine world. Her empathetic, feminine approach to serving and integrating psychoactive medicines has made Flor one of the most sought after psycho-spiritual entrepreneurs in the world.

M.D., Ph.D Svetlana Vodolazhskaya

MEDICAL DIRECTOR

M.D., Ph.D Svetlana Vodolazhskaya

MEDICAL DIRECTOR

Svetlana is a MD from USC and has a Ph.D. in Psychology from USM. Founder of Eastern Clinical Trials (CRO) with over ten years of management experience. Svetlana has operated in multiple countries conducting clinical trials for major Pharma companies such as Boehringer Ingelheim, Amgen, Hoffman La Roche, Quintiles, and various biotech companies. Svetlana is a highly accomplished communicator, experienced in Managing Operations and Business Development, as well as fundraising.

Dr. Mia Black

DIRECTOR OF NANAS

Dr. Mia Black

DIRECTOR OF NANAS

After over a decade working in psychology with an emphasis on healing trauma and addiction, Mia has seen particular success serving entheogenic medicines to Navy SEALs and professional athletes with traumatic brain injury and PTSD, as well as individuals experiencing a wide array of mental health disorders.

Jeffrey O’Brien

COMMUNICATIONS

Jeffrey O’Brien

COMMUNICATIONS

Jeff spent 12 years as a senior editor at FORTUNE and WIRED, where he and his colleagues received two National Magazine Awards for General Excellence. He's the recipient of several individual journalism honors.

Advisory Board

Rick Doblin

THOUGHT LEADER

Rick Doblin

THOUGHT LEADER

Founder and executive director of MAPS (the Multidisciplinary Association for Psychedelic Studies) and pioneer i n psychedelic medicine research and policy. MAPS is leading the legalization of MDMA therapy for PTSD already in Phase III under FDA. Advising Nana’s 501c(3), an uncompensated position.

Amanda Feilding

THOUGHT LEADER

Amanda Feilding

THOUGHT LEADER

Countess of Wemyss, is an English artist, scientist, drug policy reformer, and founder director of the Beckley Foundation. She has established a network of collaborative programs with leading scientific institutions around the world. Including the Imperial College of London Research program. Advising Nana’s 501c(3), an uncompensated position.

Martin Polanco MD

MD MEDICAL

Martin Polanco MD

MD MEDICAL

Founder and medical director at Crossroads Treatment Center in Mexico, which demonstrated an effective mental health treatment model using psychedelics. He has contributed to the body of psychedelic research specifically focused on outcome and phenomenological studies of ibogaine and 5 -MeO-DMT. Martin’s work has been portrayed in Tim Ferriss book "Tools of Titans".

Bjarke Ingels

DESIGN THINKING

Bjarke Ingels

DESIGN THINKING

Visionary architect named by TIME Magazine 100 most influential people in the world. He is known for his designs that incorporate bold sociological concepts, introducing the ludic component in to urban developments. He has designed the new Two World Trade Center, the Floating City of James Cameron, the city of Mars, and Google HQ.

Alan Faena

CULTURE & EXPERIENCE

Alan Faena

CULTURE & EXPERIENCE

Visionary entrepreneur and real estate developer creator of Faena District in Buenos Aires & Miami Beach, offering a holistic experience unifying hospitality, entertainment, art, spa & healing, housing and shopping. In partnership with architect Rem Koolhaas, designer Philip Stark and developer Foster + Partners, Faena expanded his brand from his native Buenos Aires to Miami Beach with a $1 billion project to develop a six block waterfront property, winning over 30 awards with both developments.

Dustin Robinson

LEGAL

Dustin Robinson

LEGAL

Dustin is a leader within the psychedelic ecosystem. As a licensed attorney and CPA with a law firm that exclusively works in the cannabis and psychedelic space and as the founder of a leading non-profit that is paving the way for psychedelic legal reform and spearheading research, Dustin is an expert in understanding and capitalizing on opportunities within highly regulated industries. Dustin is also the Managing Partner of Iter Investments, which is a venture capital fund investing across the psychedelic value-chain.